This new study from Venture Planning Group contains 610 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers. Rationale The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Italy Market Overview
- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases
by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic
reagent kits and components.
- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic
assays. - A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular
diagnostic technologies and products. Competitive Assessments - Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements
and new technologies/products in R&D.
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- Biotest
- Caliper
- Cepheid
- Decode
- Diadexus
- Eiken
- Enzo
- Exact Sciences
- Fujirebio/Innogenetics
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Life Technologies/Thermo Fisher
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group - Comprehensive listings of companies developing and marketing infectious disease molecular
diagnostic products, by test and application. Opportunities and Strategic Recommendations - Specific new product development opportunities with potentially significant market appeal
during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Contains 610 pages and 26 tables
|